Clinical Applications of Quantitative Imaging and Artificial Intelligence for Pancreatic Cance [0.03%]
定量影像和人工智能技术在胰腺癌诊疗中的应用前景
Yeseul Kim,David Martinus,Taydan T Tran et al.
Yeseul Kim et al.
Pancreatic cancer remains as a leading cause of cancer death in the United States due to the disease's deadly combination of evasiveness to detection, aggressive biology, and resistance to treatment. Quantitative imaging and artificial inte...
Beyond Opioids in Pancreatic Cancer: Palliative Radiotherapy and Celiac Plexus Radiosurgery [0.03%]
胰腺癌综合镇痛治疗：姑息性放疗和腹腔神经丛放射手术
Marcin Miszczyk,Ross A Abrams,Yaacov R Lawrence
Marcin Miszczyk
This review examines established and evolving approaches for radiation therapy as a palliative treatment modality in patients with pancreatic cancer within the context of effective patient-provider communication and early palliative care te...
Quality and Quantity: Dual Benefits of Ablative Radiation in Oligometastatic Pancreatic Cancer [0.03%]
质与量：寡转移性胰腺癌患者消融放疗的双重获益分析
Todd A Aguilera,Ahmed M Elamir,Ethan B Ludmir
Todd A Aguilera
Oligometastatic pancreatic cancer (OPanc) poses significant opportunities in management, as increasingly metastases can be safely and effectively targeted with local therapy. We review the existing literature on SABR for OPanc, highlighting...
Ahmed Elguindy,Dukagjin Blakaj,John Grecula et al.
Ahmed Elguindy et al.
Pancreatic cancer (PDAC) remains a challenging disease to treat with a poor prognosis. Management of PDAC has evolved over the last several decades with the development of more effective systemic therapy making local control of the primary ...
Optimal Target Volume Delineation for Pancreatic Cancer: Triangulating What Should be Targeted [0.03%]
胰腺癌的最优靶区勾画：确定真正应该被照射的区域
Amol Narang
Amol Narang
Optimal target volume delineation for pancreatic cancer remains an unanswered question across all stages of disease. To-date, target volume delineation has been highly variable across major clinical trials that have explored the role of rad...
Alden D&#x;Souza,Shannon Jiang,Michael D Chuong et al.
Alden D&#x;Souza et al.
Definitive Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer: Historical Review, Current State and Future Directions [0.03%]
不可手术局部晚期胰腺癌 definitive radiotherapy：历史回顾、现状及未来方向
Anjalika R Kumar,Nina N Sanford
Anjalika R Kumar
Based on available Level 1 evidence, standard dose conventional chemoradiation does not improve survival in patients with locally advanced pancreas cancer (LAPC), thus chemotherapy remains the only widely accepted therapy. Yet prognosis rem...
Contemporary Advances, Evidence, and Considerations in Preoperative Therapy for Pancreatic Ductal Adenocarcinoma [0.03%]
胰腺导管腺癌新辅助治疗的进展、证据和考虑因素
Alexander D Sherry,Alexandra K Bennett,Ryan M Carr et al.
Alexander D Sherry et al.
Localized pancreatic ductal adenocarcinoma (PDAC) has been historically associated with poor disease control outcomes following surgical resection alone. Due to the high risk of occult locoregional and distant metastatic disease and anatomi...
Adjuvant Radiation for Resected Pancreatic Cancer: Historical Review and Current State [0.03%]
胰腺癌术后辅助放疗：历史回顾与现状分析
John Starner,Yen-Ruh Wuu,Nicholas Hornstein et al.
John Starner et al.
Pancreatic cancer is the third leading cause of cancer-related deaths, projected to become the second leading cause by 2040. Curative intent resection remains the only non-palliative treatment strategy; however, the 5-year overall survival ...
Optimizing Radiation Therapy for Localized Prostate Cancer: Exploring Synergies With Androgen Deprivation Therapy and Novel Systemic Agents [0.03%]
局灶性前列腺癌放疗的优化：探索与雄激素剥夺治疗及新型系统性药物的协同作用
Krishnan R Patel,Melissa Abel,Spyridon P Basourakos et al.
Krishnan R Patel et al.
Although radiation therapy has been used as a curative treatment option for patients with localized prostate cancer for decades, there remains a continued need to improve outcomes for patients with localized disease. Systemic therapy in the...